Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mol Genet Metab ; 106(1): 104-7, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22424738

RESUMEN

PURPOSE: Pearson syndrome is a very rare metabolic disorder that is usually present in infancy with transfusion dependent macrocytic anemia and multiorgan involvement including exocrine pancreas, liver and renal tubular defects. The disease is secondary to a mitochondrial DNA deletion that is variable in size and location. Endocrine abnormalities can develop, but are usually not part of the initial presentation. We report two patients who presented with unusual endocrine manifestations, neonatal diabetes and adrenal insufficiency, who were both later diagnosed with Pearson syndrome. METHODS: Medical records were reviewed. Confirmatory testing included: mitochondrial DNA deletion testing and sequencing of the breakpoints, muscle biopsy, and bone marrow studies. RESULTS: Case 1 presented with hyperglycemia requiring insulin at birth. She had several episodes of ketoacidosis triggered by stress and labile blood glucose control. Workup for genetic causes of neonatal diabetes was negative. She had transfusion dependent anemia and died at 24 months due to multisystem organ failure. Case 2 presented with adrenal insufficiency and anemia during inturcurrent illness, requiring steroid replacement since 37 months of age. He is currently 4 years old and has mild anemia. Mitochondrial DNA studies confirmed a 4.9 kb deletion in patient 1 and a 5.1 kb deletion in patient 2. CONCLUSION: The patients reported highlight the importance of considering mitochondrial DNA disorders in patients with early onset endocrine dysfunction, and expand the knowledge about this rare mitochondrial disease.


Asunto(s)
Insuficiencia Suprarrenal , Anemia Sideroblástica/genética , ADN Mitocondrial/genética , Diabetes Mellitus , Sistema Endocrino , Enfermedades Mitocondriales/genética , Eliminación de Secuencia/genética , Acil-CoA Deshidrogenasa de Cadena Larga/deficiencia , Insuficiencia Suprarrenal/genética , Insuficiencia Suprarrenal/patología , Insuficiencia Suprarrenal/terapia , Anemia/genética , Anemia/patología , Anemia Sideroblástica/complicaciones , Glucemia/genética , Glucemia/metabolismo , Síndromes Congénitos de Insuficiencia de la Médula Ósea , Discapacidades del Desarrollo/metabolismo , Discapacidades del Desarrollo/patología , Diabetes Mellitus/genética , Diabetes Mellitus/patología , Diabetes Mellitus/terapia , Sistema Endocrino/patología , Femenino , Terapia de Reemplazo de Hormonas , Humanos , Hiperglucemia/metabolismo , Hiperglucemia/patología , Recién Nacido , Insulina/administración & dosificación , Insulina/metabolismo , Errores Innatos del Metabolismo Lipídico , Masculino , Enfermedades Mitocondriales/complicaciones , Enfermedades Musculares
2.
J Perinatol ; 33(8): 657-8, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23897312

RESUMEN

Severe combined immunodeficiency (SCID) is a potentially fatal disorder characterized by defective T- and B-lymphocyte function. We describe a 34-week female twin who had developed feeding intolerance, perioral cyanosis, abdominal distension and neutropenia at 1 month of age. Despite several evaluations including an 'inconclusive' newborn screening result for SCID, the presence of profound lymphopenia was unappreciated. Eventually a diagnosis of SCID in association with adenosine deaminase deficiency was made. This case serves to emphasize the importance of newborn screening for SCID in the context of careful evaluation of clinical and laboratory findings that may be overlooked and result in a delay in the diagnosis of a potentially life-threatening condition.


Asunto(s)
Tamizaje Neonatal , Inmunodeficiencia Combinada Grave/diagnóstico , Adenosina Desaminasa/deficiencia , Enfermedades en Gemelos/diagnóstico , Femenino , Humanos , Recién Nacido
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA